In the first half of the year, Kangsheng Medical Group's losses narrowed to 10.25 million yuan | Lianhe Zaobao

Thomson Medical Group reported a loss of SGD 10.25 million in the first half of the 2026 fiscal year, a decrease from the loss of SGD 12.90 million in the previous year. At the same time, revenue increased by 7% year-on-year to SGD 21.308 million. The group released its earnings report after the market closed on Wednesday (February 11), indicating that the revenue growth was mainly due to increased income from its Singapore operations and contributions from its Malaysia oncology center. During this period, the number of consultations in Vietnam also increased, but some revenue was offset by foreign exchange fluctuations. "The revenue growth reflects that the group's core business continues to maintain growth momentum, and also demonstrates the progress made by the group in advancing its long-term transformation towards becoming a leading integrated healthcare platform in Southeast Asia." The group remains in a loss position, attributed to higher expenses related to digital transformation, marketing activities, depreciation, and amortization